Cargando…
Non-small-cell lung cancer: molecular targeted therapy and personalized medicine – drug resistance, mechanisms, and strategies
Targeted therapies for cancer bring the hope of specific treatment, providing high efficacy and in some cases lower toxicity than conventional treatment. Although targeted therapeutics have helped immensely in the treatment of several cancers, like chronic myelogenous leukemia, colon cancer, and bre...
Autores principales: | Sechler, Marybeth, Cizmic, Amber D, Avasarala, Sreedevi, Van Scoyk, Michelle, Brzezinski, Christine, Kelley, Nicole, Bikkavilli, Rama Kamesh, Winn, Robert A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656464/ https://www.ncbi.nlm.nih.gov/pubmed/23690695 http://dx.doi.org/10.2147/PGPM.S26058 |
Ejemplares similares
-
Dishevelled3 is a novel arginine methyl transferase substrate
por: Bikkavilli, Rama Kamesh, et al.
Publicado: (2012) -
hsa-miR29b, a critical downstream target of non-canonical Wnt signaling, plays an anti-proliferative role in non-small cell lung cancer cells via targeting MDM2 expression
por: Avasarala, Sreedevi, et al.
Publicado: (2013) -
Novel Role for γ-Catenin in the Regulation of Cancer Cell Migration via the Induction of Hepatocyte Growth Factor Activator Inhibitor Type 1 (HAI-1)
por: Sechler, Marybeth, et al.
Publicado: (2015) -
Heterotrimeric G-Protein, G(α16), Is a Critical Downstream Effector of Non-Canonical Wnt Signaling and a Potent Inhibitor of Transformed Cell Growth in Non Small Cell Lung Cancer
por: Avasarala, Sreedevi, et al.
Publicado: (2013) -
PRMT1 Is a Novel Regulator of Epithelial-Mesenchymal-Transition in Non-small Cell Lung Cancer
por: Avasarala, Sreedevi, et al.
Publicado: (2015)